The clinical study on valsartan combined with indapamide in the treatment of hypertension
10.3969/J.ISSN.1672-8270.2014.10.043
- VernacularTitle:缬沙坦联合吲哒帕胺治疗高血压的临床研究
- Author:
Xianghuan MENG
;
Cunliang ZHANG
;
Chunhai LIANG
- Publication Type:Journal Article
- Keywords:
Valsartan;
Indapamide;
Hypertension;
Adverse reaction
- From:
China Medical Equipment
2014;(10):120-122,123
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To explore the clinical effect of valsartan combined with indapamide in the treatment of hypertension. Methods: In our hospital in 2012 August ~ 2013 August treatment of 280 cases of hypertensive patients, all patients had drug withdrawal for 2 weeks. Were randomly divided into observation group 100 cases and control group 1, control group 2 of the 90 cases, control group 1 given valsartan, control group 2 given indapamide, the observation group were given valsartan combined with indapamide, were treated for 8 weeks. Results:three groups of patients before treatment, the blood pressure were not significantly different, after the treatment, the observation group decreased blood pressure was significantly higher than that in control group, the total efficiency had significant difference (x2=6.472, P<0.05). Conclusion:Valsartan combined with indapamide in the treatment of hypertension has fast acting, high curative effect, long duration, few adverse reactions, is the ideal choice for the treatment of hypertension, is worth the clinical promotion and application.